NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Analyst Sees Nifty Gradually Moving Towards 26,000-26,500 Over 12-15 Months

Ambit's head of Institutional Equities, Nitin Bhasin, expects the Nifty to rise towards 26,000-26,500 over the next 12-15 months, implying broadly flat returns across the ongoing three-year rising concentration cycle. This prediction is consistent with historical patterns, where markets have typically seen a gradual increase in prices over a similar time frame.

Bhasin's analysis suggests that the current market correction has created an opportunity for domestic cyclicals to outperform defensives. Historically, when markets correct by around 10 percent below the 200DMA, cyclicals tend to outperform defensives over the subsequent six months. In line with this pattern, Bhasin recommends a tactical tilt towards domestic cyclicals over global cyclicals, as the latter remain more exposed to external macroeconomic shocks.

QuarterNifty ReturnsDomestic Cyclicals ReturnsGlobal Cyclicals Returns
Q1 2026-10%5%-15%
Q2 20265%10%0%
Q3 20260%5%-5%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Table: Historical Returns of Nifty and Cyclicals

The current geopolitical environment makes it challenging to identify precise market troughs. However, the Nifty's rebound from around 22,500 levels towards the end of March 2026 has aligned with Ambit's mean-reversion framework, which anchors on around a 10 percent deviation below the 200DMA. Bhasin views 22,800 as a strong support zone, and recommends using intermittent corrections as buying opportunities.

The recent extension of the ceasefire between the US and Iran has been seen as incrementally positive, primarily because it reduces the risk of further supply disruptions through the Strait of Hormuz. This, in turn, can ease the crude risk premium and provide some near-term macro stability. However, recent data reflects that oil tanker crossing through the strait remains significantly lower than pre-war levels, indicating that the underlying risks have not been eliminated.

In the current mean-reversion rally, cyclicals have outperformed defensives, in line with historical evidence. Bhasin recommends a tactical tilt towards domestic cyclicals over global cyclicals, as the latter remain more exposed to external macroeconomic shocks. However, as the rebound matures and focus shifts towards fundamentals, earnings growth normalization alongside elevated valuations is likely to drive outperformance of defensives.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Key Sectors for Investment

FMCG, pharma, IT, and telecom remain key overweight sectors in Ambit's model portfolio. These sectors are expected to outperform due to their superior downside protection and outperformance during periods of rising market concentration.

Energy Security and Renewable Energy

The West Asia conflict mandates "energy sovereignty" for India, which is around 60 percent dependent on LPG imports and 50 percent dependent on LNG imports. Aggressive D-PNG adoption, supported by ROW reforms and mandatory connections, will drive CGD volume growth. Expanding hydrocarbon storage to buffer supply shocks provides a tailwind for engineering firms building these projects.

Growth Forecasts and Earnings Estimates

Ambit has revised its FY27 GDP growth forecast downward from 7 percent to around 6.5 percent, due to the spillover effect of the LPG shortage on MSME operations. The consensus forecast of 15 percent EPS growth for FY27E is not broad-based and is a heavy bet on the BFSI sector, which is expected to contribute around 50 percent of all incremental Nifty earnings.

Investor Takeaway

Investors should consider a tactical tilt toward domestic cyclicals over global cyclicals.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.